Seattle biotech working on treating Alzheimer's raises $44M, filing shows

The funding follows a $23.1 million Series A round in January 2021.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.